Neovascular glaucoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:94058H40.5
Who is this for?
Show terms as
4Active trials25Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Clinical phenotype terms— hover any for plain English:

Rubeosis iridisHP:0011497Retinal venous occlusionHP:0012636Abnormal uvea morphologyHP:0000553Ocular hypertensionHP:0007906Central retinal vein occlusionHP:0020166Visual acuity test abnormalityHP:0030532Abnormality of central retinal arteryHP:3000032Abnormal anterior chamber morphologyHP:0000593Abnormal posterior eye segment morphologyHP:0004329Retinal neovascularizationHP:0030666Corneal stromal edemaHP:0012040Uveal ectropionHP:0025358Conjunctival hyperemiaHP:0030953
Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events
Jan 2025Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma

Zhongnan Hospital — NA

TrialACTIVE NOT RECRUITING
May 2024Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma

Iran University of Medical Sciences — NA

TrialACTIVE NOT RECRUITING
Apr 2021KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial

Sun Yat-sen University — PHASE1

TrialACTIVE NOT RECRUITING
Nov 2020Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

Bayer

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Neovascular glaucoma.

4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

4 recruitingView all trials with filters →
Phase 11 trial
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
Phase 1
Active
PI: Xiulan Zhang, MD, PhD (Zhongshan Ophthalmic Center, Sun Yat-sen Universit) · Sites: Guangzhou, Guangdong · Age: 18–75 yrs
View on ClinicalTrials.gov ↗I'm interested →
N/A2 trials
Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma
N/A
Active
· Sites: Tehran · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma
N/A
Active
· Sites: Wuhan, Hubei · Age: 18–85 yrs
View on ClinicalTrials.gov ↗I'm interested →
Other1 trial
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Actively Recruiting
· Sites: Multiple Locations
View on ClinicalTrials.gov ↗I'm interested →

Specialists

25 foundView all specialists →
XS
Xi Shen
Specialist
PI on 1 active trial
MM
Marlene R Moster, MD
SUNRISE, FL
Specialist
PI on 1 active trial
MM
Malik Y Kahook, MD
AURORA, CO
Specialist
PI on 1 active trial
WM
Weerawat Kiddee, MD
Specialist
PI on 1 active trial
KM
Kuldar Kaljurand, MD
Specialist
PI on 1 active trial
SP
Stéphanie BAILLIF, Pr
Specialist
PI on 1 active trial
MM
Mostafa A EL-Helw, M.D.
Specialist
PI on 1 active trial
SM
Shahin Yazdani, MD
Specialist
PI on 1 active trial
YP
Ying Han, MD, PhD
SAN FRANCISCO, CA
Specialist
PI on 1 active trial
XP
Xiulan Zhang, MD, PhD
Specialist
PI on 2 active trials
LM
Ling Bai, MD,PhD
Specialist
PI on 1 active trial
NM
Naris Kitnarong, M.D.
Specialist
PI on 1 active trial
SP
Salvatore Grisanti, M.D. Prof.
Specialist
PI on 2 active trials
IM
Ivana Kim, M.D.
SEATTLE, WA
Specialist
PI on 1 active trial
AM
Assoc.Prof.Weerawat Kiddee, MD
Specialist
PI on 1 active trial
HM
Harmanjit Singh, MD
TORRANCE, CA
Specialist
PI on 1 active trial
MM
Michael Marchand, MD
Specialist
PI on 1 active trial
PP
Peter A Netland, MD, PhD
CHARLOTTESVILLE, VA
Specialist
PI on 1 active trial
JJ
Joao J Nassaralla, Jr.
Specialist
PI on 1 active trial
PF
Philip A Bloom, MB ChB FRCOphth
Specialist
PI on 1 active trial
LJ
Luiz A Melo Jr
Specialist
PI on 1 active trial
RA
Robert L Avery
Specialist
PI on 2 active trials
AJ
Augusto Paranhos Jr
Specialist
PI on 1 active trial
FG
Felix Gil-Carrasco
Specialist
PI on 1 active trial
MM
Marlene M Moster
SUNRISE, FL
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Neovascular glaucoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Neovascular glaucomaForum →

No community posts yet. Be the first to share your experience with Neovascular glaucoma.

Start the conversation →

Latest news about Neovascular glaucoma

Disease timeline:

New recruiting trial: Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)

A new clinical trial is recruiting patients for Neovascular glaucoma

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Neovascular glaucoma

Are there clinical trials for Neovascular glaucoma?

Yes — 4 recruiting clinical trials are currently listed for Neovascular glaucoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Neovascular glaucoma?

25 specialists and care centers treating Neovascular glaucoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.